Encell Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Public

  • Employees
  • 112

Employees

  • Stock Symbol
  • 456070

Stock Symbol

  • Share Price
  • $3.25
  • (As of Friday Closing)

Encell General Information

Description

ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

Contact Information

Website
www.encellinc.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Songpa Terra Tower 2, 201 Songpa-daero
  • Songpa-gu
  • Seoul
  • South Korea
+82
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Stock Exchange
KRX
Vertical(s)
LOHAS & Wellness, HealthTech, Life Sciences
Corporate Office
  • Songpa Terra Tower 2, 201 Songpa-daero
  • Songpa-gu
  • Seoul
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Encell Stock Performance

As of 13-Nov-2026, Encell’s stock price is $3.25. Its current market cap is $35.7M with 11M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$3.25 $3.25 $2.96 - $14.18 $35.7M 11M 143K -$1.23

Encell Financials Summary

As of 30-Jun-2026, Encell has a trailing 12-month revenue of $2.87M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 40,707 125,994 104,724
Revenue 2,869 3,695 5,284 8,051
EBITDA (10,181) (8,586) (8,067) 397
Net Income (13,519) (11,318) (11,147) (3,865)
Total Assets 35,697 44,245 37,845 34,129
Total Debt 8,514 9,039 3,497 3,428
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Encell Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Encell‘s full profile, request access.

Request a free trial

Encell Patents

  • 56

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 28

    Pending

  • Expiring in next 12 mo

Encell Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026005189-A1 Peptide targeting ocular cells or tissues, and viral capsid protein and viral vector comprising same Pending 27-Jun-2024
WO-2025244441-A1 Method for screening therapeutic agent for demyelination-related diseases Pending 23-May-2024
WO-2025220973-A1 Method for selecting high-efficiency stem cells Pending 15-Apr-2024
WO-2025206784-A1 Composition for fat grafting Pending 29-Mar-2024
WO-2025127572-A1 Disuse sarcopenia animal model and use thereof Inactive 11-Dec-2023 A01K67/027
To view Encell’s complete patent history, request access »

Encell Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Encell ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Encell’s complete esg history, request access »

Encell FAQs

  • When was Encell founded?

    Encell was founded in 2018.

  • Where is Encell headquartered?

    Encell is headquartered in Seoul, South Korea.

  • What is the size of Encell?

    Encell has 112 total employees.

  • What industry is Encell in?

    Encell’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is Encell a private or public company?

    Encell is a Public company.

  • What is Encell’s stock symbol?

    The ticker symbol for Encell is 456070.

  • What is the current stock price of Encell?

    As of 13-Nov-2026 the stock price of Encell is $3.25.

  • What is the current market cap of Encell?

    The current market capitalization of Encell is $35.7M.

  • What is Encell’s current revenue?

    The trailing twelve month revenue for Encell is $2.87M.

  • What is Encell’s annual earnings per share (EPS)?

    Encell’s EPS for 12 months was -$1.23.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process